Sanofi India Ltd Summary Sanofi India Limited, was initially incorporated as Aventis Pharma Limited in May, 1956. The Company changed its name from Aventis Pharma Limited to Sanofi India Limited ...

Eli Lilly and Boehringer Ingelheim will undercut Sanofi by 15% with Basaglar, a biosimilar version of the insulin blockbuster Lantus launched today in the US. Basaglar will also undercut Sanofi ...

Technology can fail and that means for insulin pump users, backup insulin and knowing how to navigate customer care and technical support is critical.

Some of Sanofi’s highest earnings have come from products such as type 1 and type 2 diabetes treatments Lantus (insulin analogue) and Lantus Solostar, as well as colorectal cancer drug Eloxatin ...

For example, unbranded versions with list-price discounts were launched for infliximab (Remicade), insulin glargine (Lantus), adalimumab (Humira) and ustekinumab (Stelara) in response to ...

DiabetesMine explores how long a person with diabetes can live without insulin and how they can prolong life.

Spotlight On: Lantus® / Lantus® SoloSTAR® (insulin glargine recombinant) / Basaglar® (insulin glargine) / Semglee® (insulin... Venable LLP on 6/16/2025 ...

Under a new U.S. Patent and Trademark Office (“USPTO”) policy issued in March 2025, pre-institution inter partes review (“IPR”) proceedings are now bifurcated, consisting of a first phase ...